Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
47,722,082
-
Share change
-
-2,688,518
-
Total reported value
-
$4,603,357,006
-
Put/Call ratio
-
193%
-
Price per share
-
$96.43
-
Number of holders
-
642
-
Value change
-
-$272,152,751
-
Number of buys
-
207
-
Number of sells
-
334
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2018
As of 31 Dec 2018 ISHARES TR - ISHARES BIOTECH (IBB) had 642 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,722,082 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, DEUTSCHE BANK AG\, GOLDMAN SACHS GROUP INC, CITIGROUP INC, JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, and NATIXIS.
This table shows 642 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.